HRTX logo

Heron Therapeutics (HRTX) Depreciation And Amortization

Annual D&A

$2.90 M
+$10.00 K+0.35%

December 31, 2023

Summary

Performance

1-Year Change

+0.35%

3-Year Change

+1.83%

5-Year Change

+91.61%

15-Year Change

+89.35%

HRTX Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

56.35%
HRTX annual depreciation & amortization is higher than 56.35% of companies in Healthcare sector

High & Low

All-time High

$3.02 M
HRTX annual depreciation & amortization is currently -4.04% below its historical high of $3.02 million

3-Year Low

$2.89 M
HRTX annual depreciation & amortization is currently +0.35% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
HRTX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 12, 2025
HRTX next annual earnings announcement is scheduled for Mar 12, 2025

Related metrics

Annual Total Expenses

$237.66 M
HRTX annual total expenses is $237.66 million

Annual Operating Expenses

$172.55 M
HRTX annual total operating expenses is $172.55 million

Annual Cost Of Goods Sold

$65.11 M
HRTX annual cost of goods sold is $65.11 million

Annual Interest Expense

$3.87 M
HRTX annual interest expense is $3.87 million

Quarterly D&A

$581.00 K
-$60.00 K-9.36%

September 30, 2024

Summary

Performance

3-Month Change

-9.36%

1-Year Change

-9.36%

3-Year Change

-22.94%

5-Year Change

+11.52%

HRTX Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

51.68%
HRTX quarterly depreciation & amortization is higher than 51.68% of companies in Healthcare sector

High & Low

All-time High

$794.00 K
HRTX quarterly depreciation & amortization is currently -26.83% below its historical high of $794.00 thousand

3-Year Low

$581.00 K
HRTX quarterly depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
HRTX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
HRTX next earnings announcement is scheduled for Mar 12, 2025

Related metrics

Quarterly Total Expenses

$37.27 M
HRTX quarterly total expenses is $37.27 million

Quarterly Operating Expenses

$27.81 M
HRTX quarterly total operating expenses is $27.81 million

Quarterly Cost Of Goods Sold

$9.46 M
HRTX quarterly cost of goods sold is $9.46 million

Quarterly Interest Expense

-
HRTX quarterly interest expense value is unknown

TTM D&A

$2.63 M
-$146.00 K-5.27%

September 30, 2024

Summary

Performance

3-Month Change

-5.27%

1-Year Change

-5.27%

3-Year Change

-10.65%

5-Year Change

+28.47%

HRTX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.14%
HRTX TTM depreciation & amortization is higher than 53.14% of companies in Healthcare sector

High & Low

All-time High

$3.02 M
HRTX TTM depreciation & amortization is currently -13.08% below its historical high of $3.02 million

3-Year Low

$2.63 M
HRTX TTM depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
HRTX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
HRTX next earnings announcement is scheduled for Mar 12, 2025

Related metrics

Annual Total Expenses

$237.66 M
HRTX annual total expenses is $237.66 million

Annual Operating Expenses

$172.55 M
HRTX annual total operating expenses is $172.55 million

TTM Cost Of Goods Sold

$38.30 M
HRTX TTM cost of goods sold is $38.30 million

TTM Interest Expense

-
HRTX TTM interest expense value is unknown

HRTX Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.3%-9.4%-5.3%
3 y3 years+1.8%-22.9%-10.7%
5 y5 years+91.6%+11.5%+28.5%

HRTX Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-4.0%+0.3%-26.8%at low-13.1%at low
5 y5-year-4.0%+41.8%-26.8%+3.0%-13.1%+28.5%
alltimeall time-4.0%+1288.1%-26.8%+196.8%-13.1%+537.7%

Heron Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$581.00 K(-9.4%)
$2.63 M(-5.3%)
Jun 2024
-
$641.00 K(-7.0%)
$2.77 M(-3.4%)
Mar 2024
-
$689.00 K(-3.6%)
$2.87 M(-1.0%)
Dec 2023
$2.90 M(+0.3%)
$715.00 K(-1.7%)
$2.90 M(-2.6%)
Sep 2023
-
$727.00 K(-1.6%)
$2.98 M(+0.7%)
Jun 2023
-
$739.00 K(+2.9%)
$2.95 M(+2.4%)
Mar 2023
-
$718.00 K(-9.2%)
$2.89 M(-0.1%)
Dec 2022
$2.89 M(-4.4%)
$791.00 K(+12.0%)
$2.89 M(-0.1%)
Sep 2022
-
$706.00 K(+5.2%)
$2.89 M(-1.6%)
Jun 2022
-
$671.00 K(-6.9%)
$2.94 M(-2.1%)
Mar 2022
-
$721.00 K(-9.2%)
$3.00 M(-0.6%)
Dec 2021
$3.02 M(+6.1%)
$794.00 K(+5.3%)
$3.02 M(+2.8%)
Sep 2021
-
$754.00 K(+2.7%)
$2.94 M(-0.5%)
Jun 2021
-
$734.00 K(-0.7%)
$2.95 M(-0.4%)
Mar 2021
-
$739.00 K(+3.8%)
$2.96 M(+4.1%)
Dec 2020
$2.85 M(+39.3%)
$712.00 K(-7.4%)
$2.85 M(+5.5%)
Sep 2020
-
$769.00 K(+3.2%)
$2.70 M(+10.1%)
Jun 2020
-
$745.00 K(+20.0%)
$2.45 M(+11.5%)
Mar 2020
-
$621.00 K(+10.1%)
$2.20 M(+7.5%)
Dec 2019
$2.04 M(+35.1%)
$564.00 K(+8.3%)
$2.04 M(+7.6%)
Sep 2019
-
$521.00 K(+5.9%)
$1.90 M(+7.9%)
Jun 2019
-
$492.00 K(+5.4%)
$1.76 M(+10.1%)
Mar 2019
-
$467.00 K(+11.2%)
$1.60 M(+5.7%)
Dec 2018
$1.51 M(-1.2%)
$420.00 K(+9.9%)
$1.51 M(+2.4%)
Sep 2018
-
$382.00 K(+15.8%)
$1.48 M(-1.5%)
Jun 2018
-
$330.00 K(-13.4%)
$1.50 M(-5.2%)
Mar 2018
-
$381.00 K(-1.0%)
$1.58 M(+3.4%)
Dec 2017
$1.53 M(+39.3%)
$385.00 K(-4.9%)
$1.53 M(+5.4%)
Sep 2017
-
$405.00 K(-1.7%)
$1.45 M(+7.5%)
Jun 2017
-
$412.00 K(+25.2%)
$1.35 M(+13.5%)
Mar 2017
-
$329.00 K(+7.5%)
$1.19 M(+8.3%)
Dec 2016
$1.10 M(+49.7%)
$306.00 K(+0.7%)
$1.10 M(+6.8%)
Sep 2016
-
$304.00 K(+21.1%)
$1.03 M(+14.3%)
Jun 2016
-
$251.00 K(+5.5%)
$900.00 K(+9.8%)
Mar 2016
-
$238.00 K(+0.8%)
$820.00 K(+11.7%)
Dec 2015
$734.00 K(+27.0%)
$236.00 K(+34.9%)
$734.00 K(+6.8%)
Sep 2015
-
$175.00 K(+2.3%)
$687.00 K(+3.8%)
Jun 2015
-
$171.00 K(+12.5%)
$662.00 K(+7.5%)
Mar 2015
-
$152.00 K(-19.6%)
$616.00 K(+6.6%)
Dec 2014
$578.00 K(+73.6%)
$189.00 K(+26.0%)
$578.00 K(+19.2%)
Sep 2014
-
$150.00 K(+20.0%)
$485.00 K(+14.7%)
Jun 2014
-
$125.00 K(+9.6%)
$423.00 K(+12.2%)
Mar 2014
-
$114.00 K(+18.8%)
$377.00 K(+13.2%)
Dec 2013
$333.00 K(+69.0%)
$96.00 K(+9.1%)
$333.00 K(+16.0%)
Sep 2013
-
$88.00 K(+11.4%)
$287.00 K(+13.9%)
Jun 2013
-
$79.00 K(+12.9%)
$252.00 K(+16.7%)
Mar 2013
-
$70.00 K(+40.0%)
$216.00 K(+9.6%)
Dec 2012
$197.00 K(+10.1%)
$50.00 K(-5.7%)
$197.00 K(+4.2%)
Sep 2012
-
$53.00 K(+23.3%)
$189.00 K(+5.6%)
Jun 2012
-
$43.00 K(-15.7%)
$179.00 K(-1.6%)
Mar 2012
-
$51.00 K(+21.4%)
$182.00 K(+1.7%)
Dec 2011
$179.00 K(-21.1%)
$42.00 K(-2.3%)
$179.00 K(-3.8%)
Sep 2011
-
$43.00 K(-6.5%)
$186.00 K(-6.1%)
Jun 2011
-
$46.00 K(-4.2%)
$198.00 K(-4.8%)
Mar 2011
-
$48.00 K(-2.0%)
$208.00 K(-8.4%)
Dec 2010
$227.00 K(-36.2%)
$49.00 K(-10.9%)
$227.00 K(-14.0%)
Sep 2010
-
$55.00 K(-1.8%)
$264.00 K(-11.1%)
Jun 2010
-
$56.00 K(-16.4%)
$297.00 K(-9.5%)
Mar 2010
-
$67.00 K(-22.1%)
$328.00 K(-7.9%)
Dec 2009
$356.00 K(-13.6%)
$86.00 K(-2.3%)
$356.00 K(-4.3%)
Sep 2009
-
$88.00 K(+1.1%)
$372.00 K(-4.6%)
Jun 2009
-
$87.00 K(-8.4%)
$390.00 K(-4.6%)
Mar 2009
-
$95.00 K(-6.9%)
$409.00 K(-0.7%)
Dec 2008
$412.00 K(+42.6%)
$102.00 K(-3.8%)
$412.00 K(+3.5%)
Sep 2008
-
$106.00 K(0.0%)
$398.00 K(-1426.7%)
Jun 2008
-
$106.00 K(+8.2%)
-$30.00 K(-109.6%)
Mar 2008
-
$98.00 K(+11.4%)
$314.00 K(+8.7%)
DateAnnualQuarterlyTTM
Dec 2007
$289.00 K(-218.4%)
$88.00 K(-127.3%)
$289.00 K(-190.3%)
Sep 2007
-
-$322.00 K(-171.6%)
-$320.00 K(-459.6%)
Jun 2007
-
$450.00 K(+516.4%)
$89.00 K(-133.2%)
Mar 2007
-
$73.00 K(-114.0%)
-$268.00 K(+9.8%)
Dec 2006
-$244.00 K(-154.7%)
-$521.00 K(-698.9%)
-$244.00 K(-142.4%)
Sep 2006
-
$87.00 K(-6.5%)
$575.00 K(+42.3%)
Jun 2006
-
$93.00 K(-4.1%)
$404.00 K(-6.9%)
Mar 2006
-
$97.00 K(-67.4%)
$434.00 K(-2.7%)
Dec 2005
$446.00 K(-29.2%)
$298.00 K(-454.8%)
$446.00 K(-20.4%)
Sep 2005
-
-$84.00 K(-168.3%)
$560.00 K(-22.0%)
Jun 2005
-
$123.00 K(+12.8%)
$718.00 K(+4.1%)
Mar 2005
-
$109.00 K(-73.5%)
$690.00 K(+9.5%)
Dec 2004
$630.00 K(-3.5%)
$412.00 K(+456.8%)
$630.00 K(+29.6%)
Sep 2004
-
$74.00 K(-22.1%)
$486.00 K(-13.5%)
Jun 2004
-
$95.00 K(+93.9%)
$562.00 K(-7.6%)
Mar 2004
-
$49.00 K(-81.7%)
$608.00 K(-6.9%)
Dec 2003
$653.00 K(+38.6%)
$268.00 K(+78.7%)
$653.00 K(+12.0%)
Sep 2003
-
$150.00 K(+6.4%)
$583.00 K(+32.8%)
Jun 2003
-
$141.00 K(+50.0%)
$439.00 K(-2.9%)
Mar 2003
-
$94.00 K(-52.5%)
$452.00 K(-4.0%)
Dec 2002
$471.00 K(-16.0%)
$198.00 K(+3200.0%)
$471.00 K(+72.5%)
Sep 2002
-
$6000.00(-96.1%)
$273.00 K(+2.2%)
Jun 2002
-
$154.00 K(+36.3%)
$267.00 K(+136.3%)
Mar 2002
-
$113.00 K(-43.5%)
$113.00 K(-43.5%)
Dec 2001
$561.00 K(+105.5%)
-
-
Dec 2000
$273.00 K(+36.5%)
-
-
Dec 1999
$200.00 K(+100.0%)
$200.00 K(-140.0%)
$200.00 K(-133.3%)
Sep 1999
-
-$500.00 K(-350.0%)
-$600.00 K(+500.0%)
Jun 1999
-
$200.00 K(-33.3%)
-$100.00 K(-200.0%)
Mar 1999
-
$300.00 K(-150.0%)
$100.00 K(0.0%)
Dec 1998
$100.00 K(-66.7%)
-$600.00 K(<-9900.0%)
$100.00 K(-66.7%)
Sep 1998
-
$0.00(-100.0%)
$300.00 K(-40.0%)
Jun 1998
-
$400.00 K(+33.3%)
$500.00 K(+66.7%)
Mar 1998
-
$300.00 K(-175.0%)
$300.00 K(0.0%)
Dec 1997
$300.00 K(-78.6%)
-$400.00 K(-300.0%)
$300.00 K(-62.5%)
Sep 1997
-
$200.00 K(0.0%)
$800.00 K(-27.3%)
Jun 1997
-
$200.00 K(-33.3%)
$1.10 M(-15.4%)
Mar 1997
-
$300.00 K(+200.0%)
$1.30 M(-7.1%)
Dec 1996
$1.40 M(+16.7%)
$100.00 K(-80.0%)
$1.40 M(-12.5%)
Sep 1996
-
$500.00 K(+25.0%)
$1.60 M(+14.3%)
Jun 1996
-
$400.00 K(0.0%)
$1.40 M(+7.7%)
Mar 1996
-
$400.00 K(+33.3%)
$1.30 M(+8.3%)
Dec 1995
$1.20 M(+9.1%)
$300.00 K(0.0%)
$1.20 M(-7.7%)
Sep 1995
-
$300.00 K(0.0%)
$1.30 M(+18.2%)
Jun 1995
-
$300.00 K(0.0%)
$1.10 M(0.0%)
Mar 1995
-
$300.00 K(-25.0%)
$1.10 M(0.0%)
Dec 1994
$1.10 M(-8.3%)
$400.00 K(+300.0%)
$1.10 M(0.0%)
Sep 1994
-
$100.00 K(-66.7%)
$1.10 M(-15.4%)
Jun 1994
-
$300.00 K(0.0%)
$1.30 M(0.0%)
Mar 1994
-
$300.00 K(-25.0%)
$1.30 M(+8.3%)
Dec 1993
$1.20 M(+9.1%)
$400.00 K(+33.3%)
$1.20 M(+9.1%)
Sep 1993
-
$300.00 K(0.0%)
$1.10 M(0.0%)
Jun 1993
-
$300.00 K(+50.0%)
$1.10 M(0.0%)
Mar 1993
-
$200.00 K(-33.3%)
$1.10 M(0.0%)
Dec 1992
$1.10 M(+37.5%)
$300.00 K(0.0%)
$1.10 M(+10.0%)
Sep 1992
-
$300.00 K(0.0%)
$1.00 M(+11.1%)
Jun 1992
-
$300.00 K(+50.0%)
$900.00 K(+12.5%)
Mar 1992
-
$200.00 K(0.0%)
$800.00 K(0.0%)
Dec 1991
$800.00 K(0.0%)
$200.00 K(0.0%)
$800.00 K(0.0%)
Sep 1991
-
$200.00 K(0.0%)
$800.00 K(0.0%)
Jun 1991
-
$200.00 K(0.0%)
$800.00 K(0.0%)
Mar 1991
-
$200.00 K(0.0%)
$800.00 K(0.0%)
Dec 1990
$800.00 K(+14.3%)
$200.00 K(0.0%)
$800.00 K(+33.3%)
Sep 1990
-
$200.00 K(0.0%)
$600.00 K(+50.0%)
Jun 1990
-
$200.00 K(0.0%)
$400.00 K(+100.0%)
Mar 1990
-
$200.00 K
$200.00 K
Dec 1989
$700.00 K
-
-

FAQ

  • What is Heron Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Heron Therapeutics?
  • What is Heron Therapeutics annual D&A year-on-year change?
  • What is Heron Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Heron Therapeutics?
  • What is Heron Therapeutics quarterly D&A year-on-year change?
  • What is Heron Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Heron Therapeutics?
  • What is Heron Therapeutics TTM D&A year-on-year change?

What is Heron Therapeutics annual depreciation & amortization?

The current annual D&A of HRTX is $2.90 M

What is the all time high annual D&A for Heron Therapeutics?

Heron Therapeutics all-time high annual depreciation & amortization is $3.02 M

What is Heron Therapeutics annual D&A year-on-year change?

Over the past year, HRTX annual depreciation & amortization has changed by +$10.00 K (+0.35%)

What is Heron Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of HRTX is $581.00 K

What is the all time high quarterly D&A for Heron Therapeutics?

Heron Therapeutics all-time high quarterly depreciation & amortization is $794.00 K

What is Heron Therapeutics quarterly D&A year-on-year change?

Over the past year, HRTX quarterly depreciation & amortization has changed by -$60.00 K (-9.36%)

What is Heron Therapeutics TTM depreciation & amortization?

The current TTM D&A of HRTX is $2.63 M

What is the all time high TTM D&A for Heron Therapeutics?

Heron Therapeutics all-time high TTM depreciation & amortization is $3.02 M

What is Heron Therapeutics TTM D&A year-on-year change?

Over the past year, HRTX TTM depreciation & amortization has changed by -$146.00 K (-5.27%)